Microsoft
MSFT
NVIDIA
NVDA
Tesla
TSLA
Oracle
ORCL
Broadcom
AVGO
US Stock MarketDetailed Quotes
OMIC Singular Genomics
- 19.850
- +0.140+0.71%
Trading Jan 8 10:10 ET
50.29MMarket Cap-0.57P/E (TTM)
19.850High19.758Low1.65KVolume19.830Open19.710Pre Close32.76KTurnover0.10%Turnover RatioLossP/E (Static)2.53MShares23.41052wk High0.41P/B31.88MFloat Cap5.34052wk Low--Dividend TTM1.61MShs Float1001.100Historical High--Div YieldTTM0.47%Amplitude5.340Historical Low19.803Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Singular Genomics Stock Forum
Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share
Monday, 23rd December at 8:30 am
SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ: OMIC) ("Singular Genomics" or the "Company"), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement...
📊⚡️📊
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc.
SEC·
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC ("Concentra") to acquire all o...
No comment yet